Advertisement

Topics

The Balm In Gilead Company Profile

08:17 EST 24th November 2017 | BioPortfolio


News Articles [609 Associated News Articles listed on BioPortfolio]

Global and Chinese Blemish Balm Industry, 2017 Market Research Report [Report Updated: 07042017] Prices from USD $3000

The 'Global and Chinese Blemish Balm Industry, 20122022 Market Research Report' is a professional and indepth study on the current state of the global Blemish Balm industry with a focus on the Chinese...

Are Analysts Secretly Calling Gilead A Screaming Buy?

Sometimes it turns out that great growth companies eventually run into the day when getting the growth of the past is not possible. That has been the case of Gilead Sciences Inc. (NASDAQ: GILD) since ...

Gilead Sciences to acquire Kite Pharma for $11.9B

Gilead Sciences and Kite Pharma announced that the companies have entered into a definitive agreement pursuant to which Gilead will acquire Kite for $180.00 per share in cash. The transaction, which v...

Are You Buying Gilead Sciences, Inc. for the Wrong Reason?

The best-case scenario for Gilead wasn't an FDA approval of Kymriah, but a rejection based on some reason other than the fact that it was a CAR-T therapy. While it's hard to argue that Kymriah...

Can Gilead Sciences Squeeze $12 Billion From Kite Pharma?

Gilead's last 11-figure bet turned out to be one of the best investments in biopharma history, and it's tempting to believe the company can catch lightning in a bottle once again. Unfortunatel...

Gilead Sciences Announces Third Quarter 2017 Dividend

Gilead Sciences, Inc. (Nasdaq:GILD) today announced that the company’s Board of Directors has declared a cash dividend of $0.52 per share of common stock for the third quarter o...

Gilead Sciences Announces Fourth Quarter 2017 Dividend

Gilead Sciences, Inc. (Nasdaq: GILD) today announced that the company’s Board of Directors has declared a cash dividend of $0.52 per share of common stock for the fourth quarter...

Gilead gains CAR-T approval, undercuts rival's headline price

Gilead’s CAR-T cancer therapy has been approved in the US for an aggressive form of blood cancer, indicating the company’s $12 billion acquisition on Kite Pharma could pay off. Priced at $373,000...

Drugs and Medications [131 Associated Drugs and Medications listed on BioPortfolio]

Scape spf 30 lip balm [Nupur Formulations Inc]

Scape SPF 30 Lip Balm

Bite beauty spf 15 sheer balm [Susanne Lang Fragrance Inc.]

Bite Beauty SPF 15 Sheer Balm

Tiger balm red [Tiger Balm (Malaysia) Sdn. Bhd.]

TIGER BALM RED EXTRA STRENGTH

Benefit benetint lip balm spf 15 [Benefit Cosmetics, LLC]

Benefit Benetint Lip Balm SPF 15

Lip remedy medicinal lip balm [GANZ U.S.A., LLC]

time & again LIP REMEDY medicinal lip balm with Menthol and Cocoa Seed Butter

PubMed Articles [5 Associated PubMed Articles listed on BioPortfolio]

Role Of Generics In Treatment Of Hepatitis C Infection.

With the discovery of newer and newer DAAs, the cure of Hepatitis C seems to be a reality. But their high price and availability is a big hindrance. Sofosbuvir launched by Gilead costs about $ 84000 p...

The Role of Screening and Treatment in National Progress Toward Hepatitis C Elimination - Georgia, 2015-2016.

Georgia, a country in the Caucasus region of Eurasia, has a high prevalence of hepatitis C virus (HCV) infection. In April 2015, with technical assistance from CDC, Georgia embarked on the world's fir...

Use of medicinal plants as home remedies in Primary Health Care in Blumenau - State of Santa Catarina, Brazil.

An increase in the use of alternative therapeutic practices has been observed in the past decade, especially in medicinal plants, herbal and home remedies, which has been supported by policies within ...

Randomized, Split-Face/Décolleté Comparative Trial of Procedure Enhancement System for Fractional non-Ablative Laser Resurfacing Treatment.

INTRODUCTION: A topical proprietary procedural enhancement system (PES) containing a combination of active ingredients including a tripeptide and hexapeptide (TriHex Technology™, Alastin Procedure E...

Stress-induced changes of growth, yield and bioactive compounds in lemon balm cultivars.

The aim of the present study was to investigate the impact of water deficiency on five Melissa officinalis genotypes. For three months water supply of 70% (control) and 40% (stress) of soil water capa...

Clinical Trials [24 Associated Clinical Trials listed on BioPortfolio]

Test to Determine the Effectiveness of Moisturizing Balm Used on Babies With Dry, Itchy Skin

The purpose of this 3 week study is to test the effectiveness of an over-the-counter (OTC) skin balm in infants and toddlers with mild to moderate dry, itchy skin.

Tolerance Evaluation of a Nighttime Moisturizing Balm on Babies and Adults With Eczema

The purpose of this 14-day, two phase clinical study is to test the tolerance of a new over-the-counter moisturizing balm on subjects with eczema.

A Registry for Adolescent and Pediatric Participants Who Received a Gilead Hepatitis C Virus Direct Acting Antiviral (DAA) in Gilead-Sponsored Chronic Hepatitis C Infection Trials

This Registry will enroll adolescent and pediatric participants who received at least one Gilead Hepatitis C Virus (HCV) direct acting antiviral (DAA) while participating in a Gilead-spons...

Observational Study of the Durability of Seroconversion Chronic HBV Patients Who Seroconverted in a Previous Gilead-Sponsored Study of ADV.

To investigate the durability of HBeAg seroconversion in patients with chronic hepatitis B virus infection (HBV) who have seroconverted while participating in a previous Gilead-sponsored s...

Long Term Follow-up Registry of Individuals Treated in A Gilead-Sponsored Trial in Individuals With Chronic Hepatitis B Infection

This study will evaluate the long term effects of hepatitis B virus (HBV) treatment on the HBV serologic changes and HBV DNA levels through Week 144. This registry will enroll only individ...

Companies [18 Associated Companies listed on BioPortfolio]

The Balm In Gilead

Gilead Sciences, Inc. and Boehringer Ingelheim

Gilead Sciences is a biopharmaceutical company that discovers, develops and commercializes innovative therapeutics in areas of unmet medical need. The company's mission is to adva...

Gilead Sciences Canada, Inc.

Gilead Sciences is a biopharmaceutical company that discovers, develops and commercializes innovative therapeutics in areas of unmet medical need. The company’s mission is to...

Tiger Balm

Prince of Peace Enterprises, Inc. (www.mytigerbalm.com) introduced the world-famous Tiger Balm brand to the United States mainstream market in 1986 and has been the sole licensed ...

Tiger Balm U.S.

Prince of Peace Enterprises, Inc. (www.tigerbalm.com/us) introduced the world-famous Tiger Balm brand to the United States mainstream market in 1986 and has been the sole licensed...

More Information about "The Balm In Gilead" on BioPortfolio

We have published hundreds of The Balm In Gilead news stories on BioPortfolio along with dozens of The Balm In Gilead Clinical Trials and PubMed Articles about The Balm In Gilead for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of The Balm In Gilead Companies in our database. You can also find out about relevant The Balm In Gilead Drugs and Medications on this site too.

Quick Search
Advertisement
 

Corporate Database Quicklinks



Searches Linking to this Company Record